Skip to main content
Top
Published in: Clinical Rheumatology 2/2014

01-02-2014 | Original Article

Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosis

Authors: Murray Baron, Lorinda Chung, Geneviève Gyger, Laura Hummers, Dinesh Khanna, Maureen D. Mayes, Janet E. Pope, Ami A. Shah, Virginia D. Steen, Russell Steele, Solène Tatibouet, Ariane Herrick, Ulf Müller-Ladner, Marie Hudson

Published in: Clinical Rheumatology | Issue 2/2014

Login to get access

Abstract

The objectives of this study were to develop a standard classification of digital ulcers (DUs) in systemic sclerosis (SSc) for use in observational or therapeutic studies and to assess the reliability of these definitions as well as of the measurement of ulcer area. Ten North American rheumatologists with expertise in SSc reviewed multiple photos of DUs, examined four SSc subjects with DUs, and came to a consensus on the definitions for digital, active, healed, and indeterminate ulcers. These ten raters then examined the right hand of ten SSc subjects twice and the left hand once to classify ulcers and to measure ulcer area. Weighted and Fleiss kappa were used to calculate intra- and interrater agreement on classification of ulcers, and intraclass correlation coefficient (ICC) was used to assess agreement on ulcer area. Because the traditional ICC calculations relied on a small number of ulcers, ICCs were recalculated using the results of linear mixed models to evaluate the variance components of observations on all the data. Intrarater kappa for classifying DU as not an ulcer/healed ulcer versus active/indeterminate ulcer was substantial (0.76), and interrater kappa was moderate (0.53). The ICC for ulcer area using the linear mixed models was moderate both for intrarater (0.57) and interrater (0.48) measurements. A consensus for the classification of DUs in SSc was developed, and after a training session, rheumatologists with expertise in SSc are able to reliably classify DUs and to measure ulcer area.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chung L, Fiorentino D (2006) Digital ulcers in patients with systemic sclerosis. Autoimmun Rev 5:125–128PubMedCrossRef Chung L, Fiorentino D (2006) Digital ulcers in patients with systemic sclerosis. Autoimmun Rev 5:125–128PubMedCrossRef
2.
go back to reference Steen VD, Medsger TA Jr (1997) The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 40:1984–1991PubMedCrossRef Steen VD, Medsger TA Jr (1997) The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 40:1984–1991PubMedCrossRef
3.
go back to reference Malcarne VL, Hansdottir I, McKinney A, Upchurch R, Greenbergs HL, Henstorf GH et al (2007) Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis. J Rheumatol 34:359–367PubMed Malcarne VL, Hansdottir I, McKinney A, Upchurch R, Greenbergs HL, Henstorf GH et al (2007) Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis. J Rheumatol 34:359–367PubMed
4.
go back to reference Matucci-Cerinic M, Denton CP, Furst DE, Mayes MD, Hsu VM, Carpentier P et al (2011) Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Ann Rheum Dis 70:32–38PubMedCentralPubMedCrossRef Matucci-Cerinic M, Denton CP, Furst DE, Mayes MD, Hsu VM, Carpentier P et al (2011) Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Ann Rheum Dis 70:32–38PubMedCentralPubMedCrossRef
5.
go back to reference Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E et al (2004) Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 50:3985–3993PubMedCrossRef Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E et al (2004) Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 50:3985–3993PubMedCrossRef
6.
go back to reference Abou-Raya A, Abou-Raya S, Helmii M (2008) Statins: potentially useful in therapy of systemic sclerosis-related Raynaud’s phenomenon and digital ulcers. J Rheumatol 35:1801–1808PubMed Abou-Raya A, Abou-Raya S, Helmii M (2008) Statins: potentially useful in therapy of systemic sclerosis-related Raynaud’s phenomenon and digital ulcers. J Rheumatol 35:1801–1808PubMed
7.
go back to reference Herrick AL, Roberts C, Tracey A, Silman A, Anderson M, Goodfield M et al (2009) Lack of agreement between rheumatologists in defining digital ulceration in systemic sclerosis. Arthritis Rheum 60:878–882PubMedCrossRef Herrick AL, Roberts C, Tracey A, Silman A, Anderson M, Goodfield M et al (2009) Lack of agreement between rheumatologists in defining digital ulceration in systemic sclerosis. Arthritis Rheum 60:878–882PubMedCrossRef
8.
go back to reference Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef
9.
go back to reference Shenoy PD, Kumar S, Jha LK, Choudhary SK, Singh U, Misra R et al (2010) Efficacy of tadalafil in secondary Raynaud’s phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trial. Rheumatology (Oxford) 49:2420–2428CrossRef Shenoy PD, Kumar S, Jha LK, Choudhary SK, Singh U, Misra R et al (2010) Efficacy of tadalafil in secondary Raynaud’s phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trial. Rheumatology (Oxford) 49:2420–2428CrossRef
Metadata
Title
Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosis
Authors
Murray Baron
Lorinda Chung
Geneviève Gyger
Laura Hummers
Dinesh Khanna
Maureen D. Mayes
Janet E. Pope
Ami A. Shah
Virginia D. Steen
Russell Steele
Solène Tatibouet
Ariane Herrick
Ulf Müller-Ladner
Marie Hudson
Publication date
01-02-2014
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 2/2014
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2460-7

Other articles of this Issue 2/2014

Clinical Rheumatology 2/2014 Go to the issue